Wanrudee Isaranuwatchai

PhD

Affiliate Scientist

Biography

Dr. Wanrudee Isaranuwatchai is an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada. She is also a Program Leader and Senior Researcher of the Health Intervention and Technology Assessment Program (HITAP), Thailand.

Her research focuses on how to apply health economics and health technology assessment (HTA) in the real-world setting as well as how to advance methods in economic evaluation (EE). She has experience conducting EEs using various methods with specific interest in the potential of big data in health economics and HTA to support evidence generation and policy-making process.

She has also collaborated with researchers, health professionals, and policy-makers in various areas to help communicate the value of health initiatives using EE. She has contributed to the training on HTA to support health systems in Asia, Africa, and North America. Dr. Isaranuwatchai is dedicated to the creation and use of evidence in healthcare decision making.

Recent Publications

  1. Zanoni, P, Scime, NV, Benzies, K, McNeil, DA, Mrklas, K, Alberta FICare in Level II NICU Study Team et al.. Facilitators and barriers to implementation of Alberta family integrated care (FICare) in level II neonatal intensive care units: a qualitative process evaluation substudy of a multicentre cluster-randomised controlled trial using the consolidated framework for implementation research. BMJ Open. 2021;11 (10):e054938. doi: 10.1136/bmjopen-2021-054938. PubMed PMID:34663673 PubMed Central PMC8524282.
  2. Boulos, MI, Kamra, M, Colelli, DR, Kirolos, N, Gladstone, DJ, Boyle, K et al.. SLEAP SMART (Sleep Apnea Screening Using Mobile Ambulatory Recorders After TIA/Stroke): A Randomized Controlled Trial. Stroke. 2021; :STROKEAHA120033753. doi: 10.1161/STROKEAHA.120.033753. PubMed PMID:34628939 .
  3. Mendlowitz, A, Bremner, KE, Walker, JD, Wong, WWL, Feld, JJ, Sander, B et al.. Hepatitis C virus infection in First Nations populations in Ontario from 2006 to 2014: a population-based retrospective cohort analysis. CMAJ Open. ;9 (3):E886-E896. doi: 10.9778/cmajo.20200164. PubMed PMID:34584007 PubMed Central PMC8486470.
  4. Mendlowitz, A, Bremner, KE, Walker, JD, Wong, WWL, Feld, JJ, Sander, B et al.. Health care costs associated with hepatitis C virus infection in First Nations populations in Ontario: a retrospective matched cohort study. CMAJ Open. ;9 (3):E897-E906. doi: 10.9778/cmajo.20200247. PubMed PMID:34584004 PubMed Central PMC8486469.
  5. Rodrigues, IB, Wang, E, Keller, H, Thabane, L, Ashe, MC, Brien, S et al.. The MoveStrong program for promoting balance and functional strength training and adequate protein intake in pre-frail older adults: A pilot randomized controlled trial. PLoS One. 2021;16 (9):e0257742. doi: 10.1371/journal.pone.0257742. PubMed PMID:34559837 PubMed Central PMC8462677.
  6. Turner, HC, Archer, RA, Downey, LE, Isaranuwatchai, W, Chalkidou, K, Jit, M et al.. An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations. Front Public Health. 2021;9 :722927. doi: 10.3389/fpubh.2021.722927. PubMed PMID:34513790 PubMed Central PMC8424074.
  7. Rattanavipapong, W, Wang, Y, Butchon, R, Kittiratchakool, N, Thammatacharee, J, Teerawattananon, Y et al.. Retrospective secondary data analysis to identify high-cost users in inpatient department of hospitals in Thailand, a middle-income country with universal healthcare coverage. BMJ Open. 2021;11 (7):e047330. doi: 10.1136/bmjopen-2020-047330. PubMed PMID:34321299 PubMed Central PMC8319992.
  8. Painter, C, Isaranuwatchai, W, Prawjaeng, J, Wee, HL, Chua, BWB, Huynh, VA et al.. Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines. Appl Health Econ Health Policy. 2021;19 (4):463-472. doi: 10.1007/s40258-021-00661-5. PubMed PMID:34235643 PubMed Central PMC8263163.
  9. Millar, R, Morton, A, Bufali, MV, Engels, S, Dabak, SV, Isaranuwatchai, W et al.. Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact. Cost Eff Resour Alloc. 2021;19 (1):37. doi: 10.1186/s12962-021-00290-8. PubMed PMID:34215282 PubMed Central PMC8252304.
  10. Pataky, RE, Beca, J, Tran, D, Dai, WF, Dvorani, E, Isaranuwatchai, W et al.. Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian Provinces. MDM Policy Pract. ;6 (1):23814683211021060. doi: 10.1177/23814683211021060. PubMed PMID:34212111 PubMed Central PMC8216386.
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Institute
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
X